Assisted a Global Pharmaceutical Company in Streamlining CAPEX Procurement
When a global pharmaceutical company set out to strengthen its manufacturing and operational capabilities, the stakes were high. The business needed to procure a large volume of CAPEX items while ensuring strict compliance with GMP and FDA standards, maintaining confidentiality and controlling project costs. With multiple technical requirements, supplier dependencies and long procurement cycles slowing execution, the company partnered with us to transform its sourcing strategy into a faster, more transparent and cost-efficient process.
The Challenges
CAPEX procurement in the pharmaceutical industry is rarely straightforward. Every purchase impacts production quality, regulatory compliance and operational continuity.
The client faced several critical challenges:
Complex technical specifications related to safety, quality and compatibility with existing systems
Strict adherence to GMP and FDA regulations
Confidential handling of technical data, intellectual property and supplier information
Supplier reliability concerns that could impact project execution timelines
A highly manual and time-consuming procurement process due to the large number of CAPEX items
Limited visibility into market pricing and cost optimization opportunities
Need for value engineering to reduce total procurement costs without compromising quality
The organization also relied heavily on a limited supplier base, increasing supply chain risks and reducing negotiation leverage.
The Approach
YCP Supply Chain designed a structured sourcing and procurement transformation program focused on improving supplier discovery, accelerating sourcing timelines and reducing total landed costs.
1. Consolidating Technical and Commercial Data
The first step involved creating a centralized view of all procurement requirements.
The team collaborated closely with:
Procurement teams
Engineering and maintenance departments
Quality assurance teams
Together, they gathered:
Technical specifications
Equipment drawings
Regulatory documentation
Quality standards
Quantity requirements
Cost and maintenance data
Market intelligence and lead-time benchmarks
This created a strong foundation for supplier evaluation and pricing analysis.
2. Building a Smarter Price Discovery Process
Instead of relying on traditional negotiations, YCP Supply Chain implemented a data-driven sourcing strategy.
The process included:
Detailed cost modeling
Supplier cost engagement
Market benchmarking
Competitive pricing analysis
Negotiation strategy development
This enabled the client to make informed sourcing decisions based on total cost of ownership (TCO) rather than only upfront pricing.
3. Expanding the Supplier Ecosystem
To reduce dependency on existing vendors, the team identified six new suppliers through an e-procurement platform and extensive market intelligence research.
Supplier evaluation focused on:
Manufacturing capabilities
Quality management systems
GMP compliance
Logistics reliability
Production capacity
Industry reputation
Project delivery timelines
An extensive Request for Information (RFI) and Request for Proposal (RFP) process was conducted to validate supplier capabilities and collect detailed commercial inputs.
4. Conducting Detailed TCO Analysis
The sourcing exercise went beyond purchase price comparisons.
The team evaluated:
Material costs
Manufacturing costs
Customization expenses
Logistics costs
Service and maintenance charges
Minimum order quantity commitments
This helped identify suppliers capable of delivering long-term value while maintaining compliance and operational efficiency.
Impact
The transformation delivered measurable operational and financial improvements across the procurement function.
Outcome
By combining structured sourcing, supplier diversification and data-driven procurement strategies, we helped the pharmaceutical company transform a complex CAPEX procurement process into a faster, more resilient and cost-efficient operation.